Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1993
11/09/1993CA1324133C N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
11/09/1993CA1324131C 2-(heterocyclylalkyl)imidazopyridines
11/09/1993CA1324130C Oxaza heterocycles and pharmaceutical compositions containing same
11/09/1993CA1324095C Recombinant ricin toxin
11/09/1993CA1324084C Method of extracting a physiological active substance from the husks of pine nuts and anti-contagion medicine made of said extract as principal raw material
11/07/1993CA2095174A1 Phenyl sulfonamide endothelin antagonists
11/03/1993EP0568200A2 Pharmaceutical and foodstuff compositions containing transferrius and antibacteral agents for potentiating host defense activity and the treatment of infections
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
11/03/1993EP0420883B1 Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation
11/03/1993EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993EP0374182B1 Biospecific polymers
11/03/1993CN1077991A Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/03/1993CN1077958A Triazolopyridazine compounds, their production and use
11/02/1993US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process
11/02/1993US5258374 Administering furosemide
10/1993
10/28/1993WO1993021321A2 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021223A1 Methods and reagents for diagnosis of autoantibodies
10/28/1993WO1993021222A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993WO1993021198A1 Novel sialylsteroid
10/28/1993WO1993021149A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
10/28/1993WO1993020849A1 Low toxicity interleukin-2 analogues for use in immunotherapy
10/28/1993WO1993020847A1 Vaccine adjuvant
10/28/1993WO1993020842A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993WO1993020840A1 Induction of ctl responses
10/28/1993WO1993020831A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins
10/28/1993WO1993020803A1 Method and composition for the treatment of disorders involving immunological dysfunction
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993CA2133749A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993CA2118502A1 Supression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993CA2118026A1 Induction of ctl responses
10/28/1993CA2117779A1 T cell epitopes of the major allergens from ambrosia artemisifolia
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0566593A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
10/26/1993US5256789 Antiinflammatory hydroxamic acids and N-hydroxyureas
10/26/1993US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation
10/26/1993US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/26/1993US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/26/1993US5256416 Extracts of the Acanthospermum hispidum plant
10/26/1993US5256411 Immune cell proliferation inhibitors
10/20/1993EP0565794A1 Induction of CTL responses
10/20/1993EP0565582A1 Novel csaids
10/20/1993EP0356484B1 Process for preparation of aloe products
10/19/1993US5254731 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing them, and preparation processes
10/19/1993US5254554 Anxiolytic agents
10/19/1993US5254553 Lipoxygenase inhibitors; skin disorders, antiinflammatory agents
10/19/1993US5254534 Adjuvant for cancer immunotherapy
10/19/1993US5254348 Transdermal therapeutic system comprising tulobuterol as active substance
10/19/1993CA1323374C 2 - furylbutyrolactones
10/19/1993CA1323306C Pharmacological agent-lipid solution preparation
10/14/1993WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
10/14/1993WO1993020080A1 Bridged bis-aryl carbinol derivatives, compositions and methods of use
10/14/1993WO1993020063A1 Unbridged bis-aryl carbinol derivatives, compositions and methods of use
10/14/1993WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors
10/14/1993WO1993019767A1 Cd28 pathway immunoregulation
10/14/1993WO1993019763A1 Rapamycin formulation for iv injection
10/14/1993WO1993019751A1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
10/14/1993WO1993019750A1 Compounds useful for treating allergic or inflammatory diseases
10/14/1993WO1993019749A1 Compounds useful for treating allergic and inflammatory diseases
10/14/1993WO1993019748A1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
10/14/1993WO1993019747A1 Compounds useful for treating allergic and inflammatory diseases
10/14/1993WO1993019720A2 Compounds
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993CA2133075A1 CD28 Pathway Immunoregulation
10/14/1993CA2132849A1 Bridged bis-aryl carbinol derivatives, compositions and methods of use
10/14/1993CA2132848A1 Unabridged bis-aryl carbinol derivatives, compositions and methods of use
10/13/1993EP0565135A1 Known and selected novel arylmethylenyl derivatives of imidazolidinones useful as antiallergy agents and antiinflammatory agents
10/13/1993EP0564805A1 (4-benzylphthalazin-1(2H)-on-2-yl)aminocarboxylic acids having antiallergic/antihistaminic activity and process for their production
10/13/1993EP0564646A1 Trapped cells and use thereof as a drug
10/13/1993CN1077198A Anti-proliferative and anti-inflammatory compounds:5-or 6-deoxy hexose monosacchardies having a saturated nitrogen containing heterocycle at the 5-or 6-position bound through the nitrogen atom
10/12/1993US5252732 D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
10/12/1993US5252601 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
10/12/1993US5252579 Macrocyclic immunomodulators
10/12/1993US5252327 Solutions containing antigen and zinc hydroxide or iron hydroxide as an adjuvant and processes for preparing such solutions
10/06/1993EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
10/06/1993EP0563475A1 Cell binding agent conjugates of derivatives of CC-1065
10/06/1993EP0563286A1 Novel csaids
10/06/1993EP0563168A1 Xanthine derivatives
10/06/1993CN1022322C Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their prepn.
10/06/1993CN1022319C Method for prepn. of tetralin derivs
10/05/1993US5250682 One pot preparation by reacting a 7-deacetylforskolin with a 3-halopropionyl halide, treating with aqueous acetonitrile and alkali hydroxide followed by reaction with an amine
10/05/1993US5250678 For autoimmune, infectious diseases, organ transplant rejection; skin diseases, antiinflammatory agents
10/05/1993CA1322752C Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same
10/05/1993CA1322715C Use of a tripeptide and composition thereof as an immunostimulating agent
10/03/1993CA2093165A1 Formulated medicines and processed foods to potentiate host defense activity, and methods for treatment of infectious diseases
09/1993
09/30/1993WO1993019196A1 ANTI-CD3 AGLYCOSYLATED IgG ANTIBODY
09/30/1993WO1993019178A2 Peptides useful for inducing tolerance
09/30/1993WO1993019068A1 PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
09/30/1993WO1993019059A1 Antiviral peptides
09/30/1993WO1993019044A1 Novel vitamin d analogues
09/30/1993WO1993018765A1 Indole derivatives with antiviral activity
09/30/1993WO1993013117A3 5- or 6-aminodeoxyfuranoside derivatives with antiinflammatory and antiproliferative activity
09/30/1993WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
09/30/1993WO1992001049A3 Cd53 cell surface antigen and use thereof
09/30/1993CA2131154A1 Antiviral peptides
09/30/1993CA2120703A1 Novel vitamin d analogues
1 ... 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 ... 1172